Treatment of chronic hepatitis C with recombinant human interferon‐α2a: Results of a randomized controlled clinical trial

Hepatology

Volumn 19, Issue 1, 1994, Pages 1-5

  Diodati, Giulio ^a   Bonetti, Paola ^a   Noventa, Franco ^a   Casarin, Carla ^a   Rugge, Massimo ^a   Scaccabarozzi, Sergio ^b   Tagger, Alessandro ^c   Pollice, Lucio ^d   Tremolada, Federico ^a   Davite, Cristina ^b   Realdi, Giuseppe ^e   Ruol, Arturo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Clinical Department   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; INTERFERON ANTIBODY; RECOMBINANT ALPHA2A INTERFERON;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; INFLUENZA; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIBODIES; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERFERON ALFA-2A; LIVER; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; TRANSAMINASES;

EID: 0028088836     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840190102     Document Type: Article

References (20)

1. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis
3. Antibody to hepatitis C virus in cryptogenic chronic liver disease
4. Controlled trial of prednisone and azathioprine in active chronic hepatitis
5. Randomized, controlled trial of recombinant human alpha interferon in patients with chronic hepatitis B
6. Treatment of chronic delta hepatitis with recombinant human alpha interferon [Abstract]
7. Treatment of chronic non‐A, non‐B hepatitis with recombinant human alpha interferon: a preliminary report
8. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double‐blind, placebo‐controlled trial
9. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicentric randomized controlled trial
10. A classification of chronic hepatitis
11. Acute and chronic hepatitis revisited: review by an international group
12. The detection of antibodies to recombinant interferon alfa‐2a in human serum
13. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis
14. Antibody to hepatitis C virus in post‐transfusion hepatitis
15. Randomized controlled trial of interferon alfa‐2a (rbe) (Roferon‐A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response
16. Virus replication and liver disease in chronic hepatitis B virus infection
17. Cell mediated cytotoxicity in hepatitis A virus infection
18. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis
19. Severe chronic active liver disease: prognostic significance of initial morphologic patterns
20. Long‐term follow up of acute and chronic non‐A, non‐B post‐transfusion hepatitis: evidence of progression to liver cirrhosis